These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 9377103

  • 41. Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022.
    Murayama T, Matsumori Y, Iwata N, Ito M, Taniguchi T, Chihara K, Matsui T.
    Jpn J Cancer Res; 1996 Jul; 87(7):743-50. PubMed ID: 8698625
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
    Chang RS, Chen TB, Bock MG, Freidinger RM, Chen R, Rosegay A, Lotti VJ.
    Mol Pharmacol; 1989 Jun; 35(6):803-8. PubMed ID: 2733696
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Diastereomeric separation of 1,5-benzodiazepines due to the presence of a chiral centre on the N-5 alkylic chain.
    Araldi GL, Donati D, Tranquillini ME, Ursini A.
    Farmaco; 1998 Jan; 53(1):49-54. PubMed ID: 9543726
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Quantitative structure-activity relationship studies on 5-phenyl-3-ureido-1,5-benzodiazepine as cholecystokinin-A receptor antagonists.
    Agrawal VK, Sharma R, Khadikar PV.
    Bioorg Med Chem; 2002 Nov; 10(11):3571-81. PubMed ID: 12213472
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Synthesis and stereochemical structure-activity relationships of 1,3-dioxoperhydropyrido[1,2-c]pyrimidine derivatives: potent and selective cholecystokinin-A receptor antagonists.
    Martín-Martínez M, Bartolomé-Nebreda JM, Gómez-Monterrey I, González-Muñiz R, García-López MT, Ballaz S, Barber A, Fortuño A, Del Río J, Herranz R.
    J Med Chem; 1997 Oct 10; 40(21):3402-7. PubMed ID: 9341915
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Novel glutamic acid derived cholecystokinin receptor ligands.
    Freidinger RM, Whitter WL, Gould NP, Holloway MK, Chang RS, Lotti VJ.
    J Med Chem; 1990 Feb 10; 33(2):591-5. PubMed ID: 2299627
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Characterization of YM022: its CCKB/gastrin receptor binding profile and antagonism to CCK-8-induced Ca2+ mobilization.
    Saita Y, Yazawa H, Honma Y, Nishida A, Miyata K, Honda K.
    Eur J Pharmacol; 1994 Oct 14; 269(2):249-54. PubMed ID: 7851501
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.
    Corringer PJ, Weng JH, Ducos B, Durieux C, Boudeau P, Bohme A, Roques BP.
    J Med Chem; 1993 Jan 08; 36(1):166-72. PubMed ID: 8421283
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Direct contractile effect of cholecystokinin octapeptide on caecal circular smooth muscle cells of guinea pig via both CCK-A and CCK-B/gastrin receptors.
    Motomura Y, Chijiiwa Y, Iwakiri Y, Nawata H.
    Life Sci; 1997 Jan 08; 60(7):499-504. PubMed ID: 9042379
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.